semaglutide and tirzepatide for weight loss vs. Semaglutide: What You Should Know Semaglutide & Tirzepatide Long Beach

17 Figure 20: Subgroup analyses for PIONEER 1 to 5, 7 to 8: A1C (%) estimated change from baseline, by baseline A1C vvvv vvvv vvv vvvvvvvv vvvvvvvvvvv vvvvvvv vvvvvvvvv vvvvvv vvvvvvvvv vvvvvv vvvvv vvvv vvvvvvvvvvvvvv vv vvvvvvvvv vvvvvvvvv vvvvvvvvvvvvvvv vv vvvvvvvvvv vv vvvvvv vvvvvvvvvvv vvvvvvv vvvvvv vvvv vvvvvvv vv v vvvvvvv vvvvvvv vvvvv vvvvv vvvvvvvv vvvvvvvvvvv vvvvvvv vvv vvvvvvv vv vvvvvvvvv vvv vvv vvvvvvvvv vvvvvvv Figure 20 was redacted at the sponsors request

Certain individualssuch as those with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2should not use GLP-1 receptor agonists

The reductions observed in glycated haemoglobin levels with tirzepatide at a dose of 5 mg, 10 mg, and 15 mg were 2.01% points, 2.24% points, and 2.30% points, respectively, compared to 1.86% points with semaglutide at a dose of 1 mg

Take Action Consult Your Doctor: Discuss your medical history and the potential benefits and risks of Semaglutide